Summary
The effect of administration for three days of acetylsalicylic acid (1500 mg/day), phenylbutazone (300 mg/day), paracetamol (1500 mg/day) and tolfenamic acid (300 mg/day) on serum concentrations of phenytoin and carbamazepine were studied in a group of patients on continuous antiepileptic therapy. When measured 10 h after the last dose of the analgesics, the only significant effect was a decrease in total serum phenytoin after three days of phenylbutazone. When six patients on continuous phenytoin therapy took phenylbutazone for two weeks there was at two days an initial decrease, followed by a significant increase in total serum phenytoin and a concomitant increase in free phenytoin in serum. Even phenylbutazone was well tolerated by most of the patients. However, its use had to be discontinued in one patients due to obvious signs of phenytoin intoxication, with concomitant increases in the serum free and total phenytoin concentrations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andreasen, P. B., Frøland, A., Skovsted, L., Andersen, S. A., Hauge, M.: Diphenylhydantoin half-life in man and its inhibition by phenylbutazone: The role of genetic factors. Acta med. Scand.193, 561–564 (1973)
Avery, G. S.: Drug treatment. Principles and practice of clinical pharmacology and therapeutics. Sydney: ADIS Press 1976
Berlin, A., Agurell, S., Borgå, O., Lund, L., Sjöqvist, F.: A micromethod for the determination of diphenylydantoin in plasma and cerebrospinal fluid — a comparison between a gas chromatographic and a spectrophotometric method. Scand. J. clin. Lab. Invest.29, 281–287 (1972)
Burns, J. J., Rose, R. K., Chenkin, T., Goldman, A., Schulert, A., Brodie, B. B.: The physiological disposition of phenylbutazone in man and a method for its estimation in biological material. J. Pharmacol. Exp. Ther.109, 346–357 (1953)
Chirigos, M. A., Udenfriend, S.: Fluorometric procedure for determining salicylic acid in biologic tissue. J. Lab. clin. Med.54, 769–772 (1959)
Christensen, L. K., Skovsted, L.: Inhibition of drug metabolism by chloramphenicol. Lancet1969/II, 1397–1399
Duncan, D. B.: Multiple range and multiple F tests. Biometrics11, 1–42 (1955)
Hansen, J. M., Kristensen, M., Skovsted, L., Christensen, L. K.: Dicoumarol-induced diphenylhydantoin intoxication. Lancet1966/I, 265–266
Hansten, P. D.: Drug Interactions, p. 60. Philadelphia: Lea & Febinger 1973
Houghton, G. W., Richens, A.: Inhibition of phenytoin metabolism by sulthiame in epileptic patients. Br. J. clin. Pharmacol.1, 59–66 (1974a)
Houghton, G. W., Richens, A.: The effect of benzodiazepines and pheneturide on phenytoin metabolism in man. Br. J. clin. Pharmacol.1, 344–345 (1974b)
Kupferberg, H. J.: Quantitative estimation of diphenylhydantoin, primidone and phenobarbitol in plasma by gas-liquid chromatography. Clin. Chim. Acta29, 283–288 (1970)
Kutt, H., Winters, W., McDowell, F.: Depression of parahydroxylation of diphenylhydantoin by antituberculous chemotherapy. Neurology16, 594–602 (1966)
Lunde, P. K. M., Rane, A., Yaffe, S. J., Lund, L., Sjöqvist, F.: Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution. Clin. Pharmacol. Ther.11, 846–855 (1970)
Marsden, C. D.: Neurology. In Textbook of Epilepsy. J. Laidlaw and A. Richens (eds.). London: Churchill Livingstone 1975
Olesen, O. V.: The influence of disulfiram and calcium carbide on the serum diphenylhydantoin. Excretion of HPPH in the urine. Arch. Neurol. (Chicago)16, 642–644 (1967)
Perucca, E., Richens, A.: Interaction between phenytoin and imipramine. Br. J. clin. Pharmacol.4, 485–486 (1977)
Richens, A.: Drug Interactions. In: Drug treatment of epilepsy. A. Richens (ed.), pp. 105–117. London: Henry Kimpton 1976
Rist Nielsen, H., Remmer, H.: Kvantitativ bestemmelse af karbamazepin (Tegretol®) i serum. Ugeskr. Laeg.131, 2200–2201 (1969)
Smyth, C. J., Bravo, J. F.: Antirheumatic drugs. Clinical pharmacological and therapeutic aspects. Drugs10, 394–425 (1975)
Solomon, H. M., Schrogie, J. J.: The effect of phenyramidol on the metabolism of diphenylhydantoin. Clin. Pharmacol. Ther.8, 554–556 (1967)
Stores, G.: Behavioural effects of antiepileptic drugs. Dev. Med. Child Neurol.17, 647–658 (1975)
Walker, S. R.: The influence of protein binding on the excretion of some sulphanilamidopyrimidines in man. J. Pharm. Pharmacol.22, 574–577 (1970)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Neuvonen, P.J., Lehtovaara, R., Bardy, A. et al. Antipyretic analgesics in patients on antiepileptic drug therapy. Eur J Clin Pharmacol 15, 263–268 (1979). https://doi.org/10.1007/BF00618515
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00618515